Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Antigen-presenting cell (APC) function refers to the process by which certain immune cells detect, process, and display antigens on their surface in a form recognizable to T cells. This is a critical step in initiating and regulating adaptive immune responses. The main professional APCs are dendritic cells, macrophages, and B lymphocytes. APCs capture pathogens or foreign molecules, degrade them into peptide fragments, load them onto MHC molecules, and display the antigen-MHC complexes on the cell surface for recognition by T cell receptors. APCs also provide co-stimulatory signals and secrete cytokines to fully activate T cells. Defects in antigen presentation can result in immunodeficiency, autoimmunity, chronic infection susceptibility, or failure of tumor surveillance. Manipulation of this function is central in vaccine development and immunotherapy strategies.
N/A
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Antigen-Presenting Cell Function (APC Function).